Successful completion of phase I/II clinical trial of VIMRxyn in brain cancer Oct. 30, 1998 No Comments
Camptothecin analogues and prodrugs described in patent literature by SCRAS Oct. 30, 1998 No Comments
Vitamin D analogue Ro-25-9716 potentially useful in treating myeloid leukemia Oct. 30, 1998 No Comments
Novel class of microtubule-destabilizing agents synthesized and evaluated at Kansas State Oct. 29, 1998 No Comments
Schering-Plough obtains promising results in phase I study of p53 gene therapy for NSCLC Oct. 28, 1998 No Comments
Genetronics targets prostate cancer as a new indication for electroporation therapy Oct. 28, 1998 No Comments